Elute Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 8
Employees
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 3

Elute General Information

Description

Developer of polymer-controlled drug delivery devices designed to help prevent bone infections and promote bone healing. The company's devices provide drug coatings for bone grafts and are used for the prevention and treatment of orthopedic and other surgical bone infections, enabling physicians and healthcare professionals to improved orthopedic treatment to their patients.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Surgical Devices
Primary Office
  • 417 Wakara Way
  • Suite 3510
  • Salt Lake City, UT 84106
  • United States
+1 (801) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Elute Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 01-Oct-2020 00.000 Completed Generating Revenue
1. Early Stage VC 31-Mar-2016 00.000 00.000 Completed Generating Revenue
To view Elute’s complete valuation and funding history, request access »

Elute Executive Team (6)

Name Title Board Seat Contact Info
Ashok Khandkar Ph.D Chief Executive Officer, President & Board Member
David Grainger Ph.D Co-Founder, Chief Scientific Officer & Board Member
Stephanie Sorensen Financial Controller
Nancy Lynch MD Clinical Advisory Board
You’re viewing 4 of 6 executive team members. Get the full list »

Elute Board Members (8)

Name Representing Role Since
Ashok Khandkar Ph.D Elute Chief Executive Officer, President & Board Member 000 0000
Cheryl Blanchard Ph.D Self Board Member 000 0000
David Grainger Ph.D Elute Co-Founder, Chief Scientific Officer & Board Member 000 0000
Dennis Farrar JD UpStart Ventures (Salt Lake City) Executive Chairman 000 0000
Jon Serbousek Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Elute Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Elute Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Keiretsu Forum Venture Capital Minority 000 0000 000000 0
BoomStartup Accelerator/Incubator Minority 000 0000 000000 0
UpStart Ventures (Salt Lake City) Venture Capital Minority 000 0000 000000 0
To view Elute’s complete investors history, request access »